C1q and HBHA-specific IL-13 levels as surrogate plasma biomarkers for monitoring tuberculosis treatment efficacy: a cross-sectional cohort study in Paraguay
Correspondence: Graciela Russomando, grusso@rieder.net.py; Jonathan Hoffmann, jonathan.hoffmann@fondation-merieux.org
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | , , , , , , , , , , , |
| Fformat: | article |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
2024
|
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.3389/fimmu.2024.1308015 http://hdl.handle.net/20.500.14066/4587 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Byddwch y cyntaf i adael sylw!